Intestinal alkaline phosphatase contributes to the reduction of severe intestinal epithelial damage

European Journal of Pharmacology

Volumn 633, Issue 1-3, 2010, Pages 71-77

  Bol Schoenmakers, Marianne ^a   Fiechter, Daniëlle ^a   Raaben, Willem ^b   Hassing, Ine ^a   Bleumink, Rob ^a   Kruijswijk, Daniëlle ^b   Maijoor, Kelly ^b   Tersteeg Zijderveld, Monique ^a   Brands, Ruud ^a   Pieters, Raymond ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b AM Pharma   (Netherlands)

Author keywords

Alkaline phosphatase; Dextran sulfate sodium; Inflammatory bowel disease; Lipopolysaccharide; M ICc12 cell line

Indexed keywords

ALKALINE PHOSPHATASE INTESTINE ISOENZYME; ALKALINE PHOSPHATASE ISOENZYME; DEXTRAN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON INJURY; CONTROLLED STUDY; CYTOKINE RELEASE; EDEMA; ENTERITIS; FEMALE; GOBLET CELL; INJURY SEVERITY; INTESTINE CELL; INTESTINE CRYPT; INTESTINE EPITHELIUM; INTESTINE INJURY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; WEIGHT REDUCTION;

ALKALINE PHOSPHATASE; ANIMALS; BUTYRATES; CELL LINE, TRANSFORMED; CELLS, CULTURED; CHEMOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; NF-KAPPA B; PEROXIDASE;

EID: 77949914949     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.01.023     Document Type: Article

References (33)

1. Bates J.M., Akerlund J., Mittge E., Guillemin K. Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe 2007, 2:371-382.
2. Bens M., Bogdanova A., Cluzeaud F., Miquerol L., Kerneis S., Kraehenbuhl J.P., Kahn A., Pringault E., Vandewalle A. Transimmortalized mouse intestinal cells (m-ICc12) that maintain a crypt phenotype. Am. J. Physiol. 1996, 270:C1666-C1674.
3. Bentala H., Verweij W.R., Huizinga-Vander Vlag A., van Loenen-Weemaes A.M., Meijer D.K., Poelstra K. Removal of phosphate from lipid A as a strategy to detoxify lipopolysaccharide. Shock 2002, 18:561-566.
4. Beumer C., Wulferink M., Raaben W., Fiechter D., Brands R., Seinen W. Calf intestinal alkaline phosphatase, a novel therapeutic drug for lipopolysaccharide (LPS)-mediated diseases, attenuates LPS toxicity in mice and piglets. J Pharmacol. Exp. Ther. 2003, 307:737-744.
5. Di Sabatino A., Morera R., Ciccocioppo R., Cazzola P., Gotti S., Tinozzi F.P., Tinozzi S., Corazza G.R. Oral butyrate for mildly to moderately active Crohn's disease. Aliment. Pharmacol. Ther. 2005, 22:789-794.
6. Fukata M., Chen A., Klepper A., Krishnareddy S., Vamadevan A.S., Thomas L.S., Xu R., Inoue H., Arditi M., Dannenberg A.J., Abreu M.T. Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine. Gastroenterology 2006, 131:862-877.
7. Fukushima K., Sasaki I., Hasegawa H., Takahashi K., Naito H., Funayama Y., Matsuno S. Sodium butyrate-induced liver-type alkaline phosphatase activity in a small intestinal epithelial cell line, IEC6. Dig. Dis. Sci. 1998, 43:1116-1123.
8. Geddes K., Philpott D.J. A new role for intestinal alkaline phosphatase in gut barrier maintenance. Gastroenterology 2008, 135:8-12.
9. Goldberg R.F., Austen W.G., Zhang X., Munene G., Mostafa G., Biswas S., McCormack M., Eberlin K.R., Nguyen J.T., Tatlidede H.S., Warren H.S., Narisawa S., Millan J.L., Hodin R.A. Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:3551-3556.
10. Gribar S.C., Anand R.J., Sodhi C.P., Hackam D.J. The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation. J. Leukoc. Biol. 2008, 83:493-498.
11. Guzman-Aranguez A., Olmo N., Turnay J., Lecona E., Perez-Ramos P., Lopez de Silanes I., Lizarbe M.A. Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5. J. Cell Biochem. 2005, 94:178-193.
12. Hornef M.W., Normark B.H., Vandewalle A., Normark S. Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells. J. Exp. Med. 2003, 198:1225-1235.
13. Koyama I., Matsunaga T., Harada T., Hokari S., Komoda T. Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylation. Clin. Biochem. 2002, 35:455-461.
14. Koyama I., Matsunaga T., Harada T., Kikuno A., Hokari S., Komoda T. Ambroxol reduces LPS toxicity mediated by induction of alkaline phosphatases in rat lung. Clin. Biochem. 2004, 37:688-693.
15. Lee S.K., Il Kim T., Kim Y.K., Choi C.H., Yang K.M., Chae B., Kim W.H. Cellular differentiation-induced attenuation of LPS response in HT-29 cells is related to the down-regulation of TLR4 expression. Biochem. Biophys. Res. Commun. 2005, 337:457-463.
16. Lee J., Mo J.H., Shen C., Rucker A.N., Raz E. Toll-like receptor signaling in intestinal epithelial cells contributes to colonic homoeostasis. Curr. Opin. Gastroenterol. 2007, 23:27-31.
17. Malo M.S., Biswas S., Abedrapo M.A., Yeh L., Chen A., Hodin R.A. The pro-inflammatory cytokines, IL-1beta and TNF-alpha, inhibit intestinal alkaline phosphatase gene expression. D. N. A. Cell Biol. 2006, 25:684-695.
18. Maslowski K.M., Vieira A.T., Ng A., Kranich J., Sierro F., Yu D., Schilter H.C., Rolph M.S., Mackay F., Artis D., Xavier R.J., Teixeira M.M., Mackay C.R. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009, 461:1282-1286.
19. Poelstra K., Bakker W., Klok P., Hardonk M., Meijer D.K.F. A physiologic function for alkaline phosphatase: endotoxin detoxification. Lab. Investig. 1997, 76:319-327.
20. Poelstra K., Bakker W.W., Klok P.A., Kamps J.A., Hardonk M.J., Meijer D.K. Dephosphorylation of endotoxin by alkaline phosphatase in vivo. Am. J. Pathol. 1997, 151:1163-1169.
21. Qureshi F.G., Leaphart C., Cetin S., Li J., Grishin A., Watkins S., Ford H.R., Hackam D.J. Increased expression and function of integrins in enterocytes by endotoxin impairs epithelial restitution. Gastroenterology 2005, 128:1012-1022.
22. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
23. Rath H.C., Schultz M., Freitag R., Dieleman L.A., Li F., Linde H.J., Scholmerich J., Sartor R.B. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect. Immun. 2001, 69:2277-2285.
24. Rhee S.H., Im E., Riegler M., Kokkotou E., O'Brien M., Pothoulakis C. Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:13610-13615.
25. Rogers M.J., Moore R., Cohen J. The relationship between faecal endotoxin and faecal microflora of the C57BL mouse. J. Hyg. (Lond) 1985, 95:397-402.
26. Sanchez de Medina F., Martinez-Augustin O., Gonzalez R., Ballester I., Nieto A., Galvez J., Zarzuelo A. Induction of alkaline phosphatase in the inflamed intestine: a novel pharmacological target for inflammatory bowel disease. Biochem. Pharmacol. 2004, 68:2317-2326.
27. Sartor R.B. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterol. 2004, 126:1620-1633.
28. Steinhart A.H., Hiruki T., Brzezinski A., Baker J.P. Treatment of left-sided ulcerative colitis with butyrate enemas: a controlled trial. Aliment. Pharmacol. Ther. 1996, 10:729-736.
29. Takayama K., Qureshi N., Raetz C.R., Ribi E., Peterson J., Cantrell J.L., Pearson F.C., Wiggins J., Johnson A.G. Influence of fine structure of lipid A on Limulus amebocyte lysate clotting and toxic activities. Infect. Immun. 1984, 45:350-355.
30. Tedelind S., Westberg F., Kjerrulf M., Vidal A. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J. Gastroenterol. 2007, 13:2826-2832.
31. Tuin A., Poelstra K., de Jager-Krikken A., Bok L., Raaben W., Velders M.P., Dijkstra G. Role of alkaline phosphatase in colitis in man and rats. Gut 2009, 58:379-387.
32. Verweij W.R., Bentala H., Huizinga-vander Vlag A., Miek van Loenen-Weemaes A., Kooi K., Meijer D.K., Poelstra K. Protection against an Escherichia coli-induced sepsis by alkaline phosphatase in mice. Shock 2004, 22:174-179.
33. Weng M., Walker W.A., Sanderson I.R. Butyrate regulates the expression of pathogen-triggered IL-8 in intestinal epithelia. Pediatr. Res. 2007, 62:542-546.